BCD 800Alternative Names: BCD-800
Latest Information Update: 16 Dec 2016
At a glance
- Originator BIOCND; Undisclosed
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Liver cirrhosis
Most Recent Events
- 16 Dec 2016 Early research in Cirrhosis in South Korea (unspecified route)